Skip to main content
PLOS One logoLink to PLOS One
. 2025 Sep 5;20(9):e0330071. doi: 10.1371/journal.pone.0330071

Modulation of cellular adhesion, contractility, and migration by MiuA: A comprehensive analysis of its biomechanical impact

Carsten Alexander Baltes 1, Friederike Nolle 1,2, Kathi Michèle Kaiser 1, Erbara Gjana 1, Kristin Sander 1, Karin Jacobs 1,3, Rhoda Joy Hawkins 4,5, Franziska Lautenschläger 1,3,*
Editor: Florian Rehfeldt6
PMCID: PMC12412958  PMID: 40911607

Abstract

Cellular adhesion and contractility are essential for cell movement. In this study, we investigated the effects of actin stabilization on adhesion properties, contractility, and cell migration. For this, we used the recently synthesized actin stabilizer miuraenamide A (MiuA), which has been discussed as a more reliable alternative to the otherwise commonly used actin stabilizer jasplakinolide. We investigated the number and size of focal adhesions in RPE-1 cells and used single-cell force spectroscopy to evaluate the adhesion properties of those cells after MiuA treatment. We showed that MiuA increases the number of focal adhesions while decreasing their size and reduces adhesion energy and force. Additionally, we investigated its effects on the contractility of RPE-1 cells by measuring their contractile energy using pattern-based contractility screening (PaCS). We found no significant change in contractility after MiuA treatment. Finally, we confined RPE-1 cells in PDMS microchannels and analyzed their migration after treatment with MiuA, showing that neither their speed nor their persistence is affected by MiuA. To check that these effects are not specific to RPE-1 cells, we also analyzed the effects of MiuA treatment in MEF cells and neutrophils. Both MEF cells and neutrophils showed the same results as the RPE-1 cells. Our measurements indicate that, although altering focal adhesions significantly reduces adhesion, it does not impact cell contractility. This finding also clarifies why amoeboid migration, which operates independently of adhesion, remains unaffected. Additionally, it explains the previously observed reduction in mesenchymal migration, which relies on adhesion-based mechanisms.

Introduction

The ability of cells to migrate is essential for a multitude of cellular processes. In general cells show two distinct modes of migration. They can either migrate in an adhesion-based manner, so called mesenchymal migration, or rely on friction forces and contractility to propel themselves forward, so called amoeboid migration. These two modes are not exclusive as some cells can switch between them and even display modes of migration that have characteristics from both [1]. For our research we decided to work with three different cell lines: RPE-1 (Retinal Pigment Epithelial) cells, MEF (Mouse Embryonic Fibroblasts) cells, and neutrophils. RPE-1 cells are a commonly used cell line that is capable of adhesion and migration. However, we specifically chose RPE-1 cells for their ability to switch between mesenchymal and amoeboid migration [1]. In a similar way, MEF cells are an adherent cell line and perform predominantly mesenchymal migration, therefore allowing us to compare them to RPE-1 cells. Lastly, neutrophils are non-adherent cells, which are differentiated from HL60 cells. They are used as a model for amoeboid migration [2] and serve our research as a control system to validate our findings in amoeboid migration of RPE-1 cells.

In their study of cell migration, Lämmermann et al. present three main processes: Actin polymerization, cellular adhesion, and cell contractility [3].

In all three processes, the cytoskeletal protein actin plays a crucial role. It is therefore a prominent target when investigating the migration behavior of cells. A variety of compounds are commonly used to modify the structure and dynamics of the actin network in cells. While these compounds have enabled the study of the migration behavior of cells in general, their effects on the underlying migration processes mentioned above remain unclear.

Substances that depolymerize the actin network, such as cytochalasin D or latrunculin A, have been used to reliably study the effects of a disassembled actin network on cellular functions, including migration [410]. Nevertheless, the stabilization of actin filaments has proven to be a significant challenge. The two most prominent actin stabilizing agents are phalloidin and jasplakinolide. The first is unable to pass through the cell membrane [11], while the effectiveness of the second is dependent on the concentration used and the duration of exposure, with optimal results requiring precise calibration [12].

Nevertheless, the actin stabilization compound jasplakinolide has been used in various studies. It has been shown to reduce migration in MDA-MB-231 and MCF7 cells in a dose dependent manner [10,13] but shows the contrary effect on A549 cells [10]. Additionally, experiments on cellular growth and apoptosis showed that jasplakinolide not only reduces cellular growth but is also capable of inducing apoptosis [14,15], as well as actin depolymerization [16].

The versatile use of jasplakinolide reflects the interest in the community of the interplay between actin stabilization and cellular mechanics. However, jasplakinolide remained the only available actin stabilizer suitable for live cell experiments for a long time.

Recently, a new compound, miuraenamide A (MiuA), has been used in studies to stabilize actin filaments in living cells and in vitro [1721]. This new tool allows investigation of the effects of actin stabilization in migration and its underlying mechanisms.

MiuA achieves this stabilizing effect by shifting the conformation of F-actin monomers [17]. MD simulations performed by Wang et al. showed that this change in conformation blocks the binding site of cofilin, an actin depolymerizing factor, which ultimately results in a decreased depolymerization rate of actin filaments and leads to an increased length of actin filaments. This effect has also been verified in vitro by Wang et al. [17]. Additionally, Gegenfurtner et al. tested the transcriptional effects of MiuA [22]. They report a net positive effect on the following categories of genes: Cellular adhesion and spreading, smooth muscle contraction and regulation of lamellipodium assembly.

In an earlier study, we demonstrated that MiuA reduces actin filament dynamics, thereby altering the first of the migration processes discussed by Lämmermann et al.: the polymerization rate. Additionally, we observed that MiuA treatment reduced mesenchymal migration in RPE-1 and MEF cells in a 2D unconfined environment [23]. Following our previous work, we wanted to understand the effects of the actin stabilizing compound MiuA on the remaining two migration mechanisms: adhesion and contractility, on amoeboid as well as mesenchymal cell migration. We therefore performed adhesion and contractility measurements on RPE-1 and on MEF cells, and employed amoeboid migration assays in PDMS microchannels using RPE-1 cells and neutrophils.

In this new study we showed that MiuA stabilizes and elongates actin filaments in RPE-1 and MEF cells and also affects the number and size of focal adhesions in those cells. We then measured the adhesion forces of the cells and found that the MiuA treated ones exert a lower adhesion force and energy. Additionally, we placed cells on a patterned soft substrate, which they deform by contracting. Measuring these deformations, we were able to calculate the contractile energy of single cells. We showed that MiuA does not affect the contractile energy of cells. Lastly, we conducted 1D migration experiments with RPE-1 cells and neutrophils confined in PDMS microchannels. MiuA did not affect the amoeboid migration behavior in either cell line.

Taken together, our findings suggest that the effect of MiuA on the length of actin filaments and focal adhesions is important in mesenchymal migration but not in amoeboid migration. This is because MiuA influences mechanisms that are key to adhesion-based migration but not essential to amoeboid migration.

Materials and methods

Cell culture

We cultured RPE-1 cells, wildtype and transfected with the LifeAct mCherry marker (as described by Maiuri et al. in 2015 [1]), and MEF cells transfected with GFP-vinculin at 37 °C and 5% CO2 in Dulbecco’s Modified Eagle Medium Nutrient Mix F12 with 10% FBS, 1% GlutaMax, and 1% Penicillin Streptomycin (Thermo Fisher). The RPE-1 cells were kindly gifted by the lab of Mathieu Piel, Institute Curie, Paris, while the MEF GFP vinculin cells were kindly given by Jennifer Kasper, Leibniz-Institute for New Materials. We cultured HL60 cells (bought from ATCC) at 37 °C and 5% CO2 in RPMI 1640 Medium (Thermo Fisher) with 10% FBS, 1% GlutaMax, and 1% Penicillin Streptomycin (Thermo Fisher). We differentiated the HL60 cells by adding 1.3% of DMSO to the medium and incubating them for two days. A list of the cells we used in this study can be seen in Table 1.

Table 1. List of the cells used in this study.

Cell line Info Provider Usage
RPE-1 LifeAct mCherry hTERT RPE-1 cells transfected with LifeAct mCherry Lab of Matthieu Piel (Paris) Migration assay (channels), Trypsin assay, Focal adhesion staining, FluidFM measurements
RPE-1 wt hTERT RPE-1 cells (wildtype) Lab of Matthieu Piel (Paris) Contractility screening, dosage dependency of MiuA
MEF GFP vinculin Transfected with GFP vinculin Dr. Jennifer Kasper, Leibniz-Institute of new materials (Saarbrücken) Focal adhesion staining, Phalloidin staining
Neutrophils HL60 cells differentiated into neutrophils HL60 cells bought from ATCC Migration assay (channels), Focal adhesion staining

Phalloidin staining

We allowed the MEF GFP vinculin cells and REP-1 wt cells to fully spread on a fibronectin-coated glass surface (fibronectin concentration 25 µg/ml). Then, we treated them with DMSO (control) and 5 nM of MiuA for 1 hour before we fixed them with 4% PFA, dissolved their membrane using a 0.1% Triton X100 solution, and washed them three times with PBS. We added a 3% BSA solution to block unspecific binding sites. After one hour, we added a 1:1000 solution of Phalloidin-iFluor 555 (abcam: ab176756) and 3% BSA for another hour. We then washed the cells three times with PBS and mounted them with Fluoromount G+DAPI.

Focal adhesion staining

We took fully spread and adhered RPE-1 LifeAct mCherry cells on fibronectin (25 µg/ml) coated glass and treated them for 1 hour with DMSO (control) or 20 nM MiuA before we fixed them with 4% PFA and dissolved their membrane. Additionally, we treated the RPE-1 LifeAct mCherry cells and the neutrophils with DMSO (control) or 20 nM MiuA before we placed them inside PDMS microchannels (coated with 25 µg/ml fibronectin or 100 µg/ml pll-g-PEG) and let them enter the channels. After at least 4 hours, we fixed those cells too with 4% PFA and dissolved their membrane. For this, we kept the cells for 10 minutes in a 0.1% Triton X100 solution and washed them afterwards three times with PBS. We added a 3% BSA solution to block unspecific binding sites. After one hour, we added a 1:1000 solution of paxillin polyclonal antibodies (ThermoFisher PA-34910) and 3% BSA. After another hour, we washed the cells three times with PBS and mounted them with Fluoromount G+DAPI. For focal adhesions in MEF GFP vinculin cells, we seeded them on a glass coverslip coated with fibronectin (25 µg/ml) and put them in the incubator for at least 4 hours. Once the cells were fully adhered, we treated them with MiuA (5 nM) or DMSO for 1 hour before we fixed them with 4% PFA and mounted them with Fluoromount G+DAPI. We repeated all experiments three times.

Trypsin assay

We seeded RPE-1 LifeAct mCherry cells on a glass coverslip coated with fibronectin (25 µg/ml) and allowed them to fully adhere. After at least four hours of spreading time, we treated the cells for one hour with DMSO (control) or 20 nM of MiuA. We placed the cells inside a microscope with temperature and CO2 control before we added trypsin and imaged the cells for 5 minutes. We took images every 20 seconds. We repeated the experiment three times.

Single-cell force spectroscopy

To measure the adhesion forces of RPE-1LifeAct mCherry cells to fibronectin, we treated tissue culture dishes (TPP, Trasadingen, Switzerland) with plasma for 3 minutes, coated them with fibronectin (25 µg/ml) and incubated them for 1 hour at room temperature. After the preparation of the culture dishes, we added RPE-1 LifeAct mCherry cells (106 cells/dish) along with the compound of interest (DMSO or MiuA). We allowed the cells to adhere to the fibronectin for 4 hours in an incubator (37 °C, 5% CO2). To perform single-cell force spectroscopy outside of a CO2 incubator, we added 25 µl of HEPES per 1 ml of cell medium to the cell medium.

We performed single-cell force measurements at 37 °C using a Nanowizard IV XP AFM with a CellHesion 200 Head (Bruker-JPK, Santa Barbara, CA, USA), a FluidFM microfluid control system V2 Platinum (Cytosurge, Glattburg, Switzerland), and a JPK PetriDishHeater. We approached (setpoint 8nN) RPE-1 LifeAct mCherry cells with a Cytosurge FluidFM micropipette (aperture 4 µm, stiffness 2 N/m) and immobilized the cells to the micropipette with a vacuum (−500 mbar) while maintaining the micropipette at a constant height or force. We then detached the cells from the fibronectin by retracting the micropipette (z-length 50 µm, z-velocity 0.8 µm/s). We used an inverted-light microscope (Zeiss AG, Oberkochen, Germany) to observe the detachment process. We analyzed the force–distance curves using JPK Data Processing Software, version 7.0.128. We repeated the experiment three times.

Contractility screening

We prepared micropatterned glass coverslips following the protocol used by Azioune et al. [31]. First, we cleaned the glass coverslips with ethanol prior to a plasma treatment lasting 3 minutes. Then, we coated the coverslip with a 50 µl droplet of a 100 µg/ml pll-g-PEG solution for 1 hour at room temperature. We washed the pegylated coverslips in pure water and placed them on an activated quartz-chromium photomask (ROSE Fotomasken, Germany) using a 4.5 µl droplet of pure water. After 6 minutes of deep-UV irradiation (200 nm), we lifted the glass coverslips from the photomask and covered them with a 50 µl droplet of a 25 µg/ml solution of fibronectin mixed with 0.1% BSA+Alexa555 (Thermo Fisher).

After at least 30 minutes, we prepared a solution of 200 µl acrylamide, 96 µl bis-acrylamide, and 198.5 µl PBS; vortexed it; and degassed it with nitrogen for a minimum of 2 minutes. To this, we added 5 µl of a 10% APS (ammonium persulphate) solution and 0.5 µl TEMED (Tetramethylethylenediamine), before mixing it with a pipette. Afterwards, we pipetted 50 µl droplets on the patterned glass coverslips and placed an acryl-silanized coverslip on top. We waited at least 15 minutes before we immersed the coverslips in PBS for a minimum of 1 hour to allow the hydrogel to swell. After this, we removed the top coverslip, which was attached to the gel and the micropatterns. We seeded 100,000 RPE-1 wildtype cells on each coverslip and placed them in the incubator overnight. The next day, we treated them for 1 hour with DMSO (control) or 20 nM of MiuA before we fixed the cells with 4% PFA. We repeated each experiment three times.

For the analysis, we measured the change in the micropattern area and calculated the contractile energy using the following formula (derived from Ghagre et al. [30] and Landau and Lifshitz Theory of Elasticity, [32,33]):

Econtractile=E(1σ)(1+σ)((2(1σ)+σ)2σ2)·3·π32 (Ai32Af32)

where

  • E is the Young’s modulus,

  • σ is the Poisson ratio (here 0.5 for an incompressible material),

  • Ai is the initial pattern area and

  • Af is the final pattern area.

Our formula differs from the one used by Ghagre et al., as we reduced the necessary parameters from two to one by solving the following equilibrium equation for an elastic deformation of a substrate in the xy-plane:

 (12σ)Δu + ( u) =0

where we used polar coordinates to describe our displacement vector u using only radial displacement.

u=(rfri) er

We present the full calculations in the SI.

Microfabrication of PDMS microchannels

We mixed the RTV615 A + B compound (Momentive) at a ratio of 10:1 and proceeded as described by Vesperini et al. [34]. The microchannels had a diameter of 10x10 µm for the RPE-1 LifeAct mCherry cells and 5x5 µm for the neutrophils. We treated all the cells with 250 ng/ml Hoechst prior to imaging. We coated the PDMS channels with 100 µg/ml poly-L-lysine-grafted poly-ethylene-glycol (=pll-g-PEG) (for the migration assays and focal adhesion staining) or 25 µg/ml of fibronectin (for focal adhesion staining) and washed them three times with PBS before we completely submerged them in the cell medium. We kept them for at least one hour in the cell medium before we added the cells. For the experiments, we added around 100,000 cells to one of the loading channels. These cells were already suspended in cell medium containing only DMSO (control) or 20 nM of MiuA. We repeated each experiment three times.

Microscopy

We imaged the fixed samples using a ZEISS Axio observer (base version: epifluorescence, non-confocal, Zeiss AG, Oberkochen, Germany) with a 63x magnification oil objective. We took time-lapse images of migrating cells with a Nikon Eclipse Ti microscope using a 10x magnification objective. We set the temperature inside the microscope’s incubation chamber to 37 °C and kept the CO2 level at 5%. To ensure that there were no fluctuations in the settings, we allowed the system to settle for one hour prior to the start of the experiments. We observed cell movement by treating living cells with 250 ng/ml Hoechst for 30 minutes before the start of the recording. We took pictures every five minutes for at least ten hours.

Image analysis

We performed image analysis with the open-source software Fiji (ImageJ) [35]. We analyzed time-lapse images of migrating cells using the plug-in TrackMate [36,37]. We determined the number and size of the focal adhesions via paxillin or vinculin staining. We used a threshold for the fluorescence signal and analyzed the images with Fiji’s “Analyze particles” function.

Statistical analysis

We conducted student’s t tests on all experimental data using a home-built Python script (t-test_ind-function from SciPy 1.14.1). We calculated the p values and assigned significance as follows: no significance (n.s.) p > 0.05, * p < 0.05, ** p < 0.01, and *** p < 0.001.

We include all exact p values in the supplementary information S1 File.

English correction

During the preparation of this work, we used ChatGPT-3 (OpenAI, 2021) and DeepL (DeepL writer, Beta, 2024) to improve the language of the manuscript. After using these tools, we reviewed and edited the content as needed and hereby take responsibility for the content of the publication.

Results and discussion

Effects of miuraenamide A on focal adhesions

The actin stabilizer miuraenamide A was first identified in 2006 by Iizuka et al. [21] and subsequently synthesized by Karmann et al. in 2015 [20]. It can enter living cells and stabilizes actin filaments by modifying the conformation of actin monomers, thereby preventing cofilin, an actin-severing protein, from accessing its binding site [17].

In this work, we first tested whether the actin stabilizing effect of MiuA applies to different cell lines.

In our previous work [23], we already reported the actin stabilizing effect in RPE-1 cells as well as the reduction of 2D migration in RPE-1 and MEF cells when treated with MiuA. However, we did not look at the effect of MiuA on the actin filament length in MEF. We have therefore now done this by seeding MEF GFP vinculin cells on glass cover slips coated with fibronectin (25 µg/ml) and allowing them to fully adhere. Fig 1a and S1 Fig shows an example of fully adhered spread cells in a side-by-side comparison between RPE-1 and MEF cells. We found that the MEF cells treated with MiuA did not increase their spreading area (Fig 1b), remaining at around 550 µm2, while the average length of their actin filaments increased from 10.2 µm in untreated cells to 19.1 µm in MiuA treated cells (Fig 1c). This effect partially aligns with the effects in RPE-1 cells that we already reported [23]. In both cell lines the average length of actin filaments increased but only RPE-1 cells showed an additional increase in spreading area. We expected to see an increase in the spreading area of MEF cells as well, since Gegenfurtner et al. [22] reported that MiuA positively influences genes related to cell spreading. We hypothesize that this effect in our case only takes place in RPE-1 cells and not in MEF cells since the concentration of MiuA was higher in RPE-1 cells (20 nM) compared to MEF cells (5 nM). When we tested different concentrations, we found 20 nM to be cytotoxic for MEF cells and therefore reduced to concentration of MiuA accordingly. Additionally, when we measured the aspect ratio and circularity of RPE-1 and MEF cells we found no significant differences (Fig 1d, 1e, 1g) or a low significance (Fig 1f, p-value ~ 0.04). The results align with our expectations. We found RPE-1 cells increased their spreading area but initially exhibited a uniform distribution of actin filaments. As all cells were treated post-adherence, we did not anticipate MiuA to alter this distribution or cell geometry. Conversely, we found MEF cells did not increase their spreading area. We propose that in MEF cells MiuA only stabilized pre-existing actin filaments and elongated within the cell’s established borders, leaving the cell geometry unaffected. Treating RPE-1 cells with a lower concentration of MiuA (5nM) resulted in longer actin filaments and an increased spreading area, but not significantly (S2 Fig). However, we conclude that the treatment with MiuA leads to an elongation and stabilization of actin filaments within living cells regardless of the cell line.

Fig 1. Effect of MiuA on actin.

Fig 1

(a) Representative images of the actin cytoskeleton in RPE-1 LifeAct mCherry and MEF GFP vinculin cells when treated with MiuA. Top: control cells. Bottom: MiuA treated cells (20 nM for RPE-1 LifeAct mCherry and 5 nM for MEF GFP vinculin). Actin filaments in MEF GFP vinculin cells were stained with Phalloidin-iFluor 555. Scale bar 20 µm. (b) Spreading area of MEF GFP vinculin cells seeded on a fibronectin-coated glass surface; untreated (control) cells and cells treated with 5 nM MiuA. (c) Mean length of actin filaments in MEF GFP vinculin cells, spread on fibronectin-coated glass surface. Effect of MiuA on the aspect Ratio of MEF (d) and RPE-1 (f) cells. Effects of MiuA on the circularity of MEF (e) and RPE-1 (g) cells. Number of cells: MEF: Control: 41, MiuA: 38; RPE-1: Control: 38, MiuA: 35. A statistical analysis was performed using Student’s t test. n.s.: p > 0.05; *: p < 0.05; **: p < 0.01; and ***: p < 0.005.

Linked to actin filaments are focal adhesions, which connect the cytoskeleton and the extracellular matrix. Focal adhesions are clusters of proteins, including integrins, paxillin, vinculin, and talin [2429]. These clusters form the connection between the outer extracellular matrix and the inner actin cytoskeleton. Although it is established that the size of focal adhesions affects the composition of the stress fibers connected to them [38], the relationship between actin filament length and focal adhesions remains largely unexplored. We therefore expected that targeting actin with MiuA would have an indirect effect on focal adhesions.

In this study we investigated the correlation between actin filament length and focal adhesion number and size. We seeded RPE-1 LifeAct mCherry and MEF GFP vinculin cells on a fibronectin-coated glass surface, treated them with MiuA, and fixed them after they had fully spread (Fig 2a-2e). Our analysis of their focal adhesions showed that the average size of focal adhesions in cells treated with MiuA was smaller than in the control group (Fig 2f, 2i). With MiuA treatment the average focal adhesion size reduced from 1.258 µm2 to 0.977 µm2 in RPE-1 cells and from 0.839 µm2 to 0.603 µm2 in MEF cells. However, the average number of focal adhesions increased significantly in RPE-1 cells (Fig 2g) from 57.8 to 103.2, and in MEF cells (Fig 2j) from 21.5 to 39.1 after treatment with MiuA. This resulted in a larger total area of focal adhesions in RPE-1 cells but not in MEF cells (Fig 2h, 2k). Unlike in RPE-1 cells, MiuA treatment of MEF cells did not change their spreading area and we therefore conclude that the total focal adhesion area normalized to the spreading area of the cells did not change.

Fig 2. Effects of MiuA on focal adhesions (FAs).

Fig 2

(a) Schematic of a cell adhering to a fibronectin-coated surface. Epifluorescence images of focal adhesions in RPE-1 LifeAct mCherry cells with paxillin stained (b)(d) as well as MEF GFP vinculin cells (c)(e). Mean and total values of FA size and their number for RPE-1 cells (f)-(h) and MEF cells (i)-(k). In both cases, the number and mean area of focal adhesions per cell increased when using MiuA. Data on the number of focal adhesions taken from Baltes et al. [23]. A statistical analysis was performed using Student’s t test. n.s.: p > 0.05; *: p < 0.05; **: p < 0.01; and ***: p < 0.005. Scale bar: 15 µm. Number of cells: RPE-1, 35 control and 34 MiuA; MEF, 90 control and 76 MiuA.

Since focal adhesions are crucial for the overall adhesion of cells, we next measured how cell adhesion differs depending on the size of their focal adhesions.

Adhesion forces

Knowing that cells with stabilized and elongated actin filaments express more but smaller focal adhesions, we next quantified the relationship between focal adhesion size and the adhesive force exerted by the cell. Previous studies on single focal adhesions have shown that there is a positive correlation between the size and the force that cells can exert on the underlying matrix [3843]. However, the effect of average focal adhesion size on the adhesion properties of cells as a whole remains unclear.

In order to measure the adhesion forces of cells, we performed single-cell force spectroscopy, a method well suited to measure the force required to detach a single-cell from the substrate to which it adheres [4446,5557]. We collected force-distance curves, allowing us to calculate adhesion parameters such as adhesion energy, force and rupture length (Fig 3a). We seeded RPE-1 cells in a plastic bottom dish coated with fibronectin (25 µg/ml). We allowed the cells to fully spread before we measured force-distance curves. We found that the basic form of the force-distance curves remained unchanged between control and MiuA treated cells, but observed significant differences in adhesion force and energy (Fig 3b,3c). From our measurements, it is evident that the addition of MiuA significantly reduced the adhesion energy of RPE-1 cells (Fig 3d), specifically the average dropped from 3.36 pJ in untreated cells to 1.06 pJ in MiuA treated cells. The average adhesion force showed the same trend (Fig 3e), such that untreated cells exhibited an average adhesion force of 0.279 µN while MiuA treatment reduced this to 0.074 µN.

Fig 3. Fluid force measurements (FluidFM) on RPE-1 cells.

Fig 3

(a) Schematic sketch of the force–distance curve and explanation of adhesion energy, adhesion force, and rupture length. Representative force–distance curves for the control (b) and MiuA-treated cells (c). The violin plots of adhesion energy (d), adhesion force (e), and rupture length (f) show that energy and force are reduced in cells with smaller FAs, while rupture length remains unchanged. A statistical analysis was performed using Student’s t test. n.s.: p > 0.05; *: p < 0.05; **: p < 0.01; and ***: p < 0.005. Number of cells: 15 control and 11 MiuA.

Despite the elongation of actin filaments in MiuA treated cells, the detachment length did not appear to increase, remaining at around 31 µm for both untreated and MiuA treated cells (Fig 3f). However, the MiuA treated cells displayed a greater spread in detachment length, which could indicate increased variation in the elongated actin filaments.

Interestingly, when we used trypsin to detach the cells, we saw that RPE-1 cells treated with MiuA took longer than the untreated cells (S3 Fig). This is contrary to the expectations from our single-cell force spectroscopy measurements. We suggest that this is due to the different mechanisms used by the two approaches. Trypsin detachment of cells is achieved by chemical degradation of adhesion sites in contrast to single-cell force spectroscopy which physically detaches cells. Since trypsin is a digestive enzyme that can degrade proteins such as integrins in focal adhesions [47], the time it takes for cells to detach after the addition of trypsin correlates with the time required for protein degradation. We propose that, due to the increased number of focal adhesion sites in MiuA-treated cells, the degradation process takes longer.

Taken together, neither the total number nor the total area of focal adhesions appear to have the most significant effect on the adhesion force and energy. Instead, the reduction in the size of the individual focal adhesions appears to have the most significant effect in reducing the adhesion force and energy.

Cell contractility

In addition to actin polymerization and cellular adhesion, cells require contraction in all types of migration [4751]. Therefore, in this work we also investigated the influence of MiuA on cell contractility.

We performed a pattern-based contractility screening assay (PaCS) [32] in which RPE-1 cells are placed on a polyacrylamide gel (Fig 4a) with a stiffness of 10 kPa. Treating the surface of these gels with fibronectin allows the cells to adhere only to a specific fluorescently labeled area, known as a micropattern [31]. These micropatterns are small enough that when a cell contracts, the underlying micropattern and substrate equally deform. By monitoring this deformation, the quantification of changes in the pattern area can be detected, thus calculating the contractile energy exerted by the cell to deform the pattern.

Fig 4. Contractile energy of RPE-1 cells on poly-acrylamide gels.

Fig 4

(a) Schematic diagram of the technique, where a cell adheres to a pattern on a soft gel and deforms it, with the red dotted lines representing the initial pattern outline. (c), (d), (e) Representation of a single cell (nucleus in yellow on a soft gel pattern (grey) showing the area before deformation as a dashed circle (red). When treated with MiuA cells do not show any significant change in contractile energy (b) or pattern area after deformation, whereas treatment with blebbistatin reduces contractile energy (e) and increases pattern area after deformation compared to control. Scale bar: 20 µm. Statistical analysis was performed using Student’s t test. n.s.: p > 0.05, *: p < 0.05, **p < 0.01, ***: p < 0.005. Number of cells: Control: 38, MiuA: 40, blebbistatin: 22.

Interestingly, we found that cells treated with MiuA did not show significant changes in contractile energy compared to untreated cells (Fig 4b). For untreated cells the average contractile energy was 4.907 pJ, while being decreased to 4.735 pJ in MiuA treated cells. To verify the sensitivity of our assay, we also treated cells with 10 µM blebbistatin, which inhibits the motor protein myosin II. As expected, the treatment with blebbistatin reduced the contractile energy of RPE-1 cells (Fig 4c-4e), dropping from approximately 4.80 pJ in untreated and MiuA treated cells to 2.61 pJ in blebbistatin treated cells. This gives us confidence that our PaCS assay is sensitive enough to detect changes in contractility and that MiuA did not alter this contractility.

Although MiuA reportedly changes the architecture of the actin network in cells, which has an impact on cellular mechanics such as adhesion, we do not know of any reports about the effects of MiuA on the interaction between actin and myosin motor proteins. Since MiuA does not disrupt the actin network and presumably does not block myosin from actin filaments, we assume that the interaction between the two is unchanged in our experiments. This explains why we observe no changes in contractility in our experiments. However, further studies on the interactions between actin, MiuA and motor proteins, especially on co-localization are required to fully answer this question.

We next tested how amoeboid migration was affected by MiuA.

Cell migration

Cells can migrate using a non-adhesive process known as amoeboid migration, which does not rely on adhesion but on friction and contractility [1,3,5254]. RPE-1 cells are known to be able to switch between migration modes, depending on the environment, and neutrophils are widely used as a model system for amoeboid migration [1,2]. To investigate the effects of MiuA treatment on amoeboid migration, we used both cell lines to avoid specific effects linked to the respective cell line. We hypothesized that amoeboid migrating cells would not be affected by actin filament stabilization as the actin stabilizer MiuA does not change their contractility. To test this, we forced RPE-1 cells to migrate in an amoeboid mode [1] by placing RPE-1 cells in confining microchannels and recording their migration speed and persistence (Fig 5a-5d). To ensure that the observed migration mode was amoeboid, we coated the PDMS microchannels with pll-g-PEG, which is known to hinder adhesion. After seeding the cells and staining their focal adhesions, we saw that the cells inside pll-g-PEG-coated channels did indeed not express focal adhesions, unlike cells within fibronectin coated channels (S4 Fig). As hypothesized, we did not find significant changes in the migration of MiuA treated RPE-1 cells in pll-g-PEG-coated channels. We measured speeds of 0.918 µm/min and 0.858 µm/min for untreated cells and MiuA treated cells respectively, while the persistence in both cases was 0.740. By “persistence” in this study we refer to the tendency of cells to change their direction while migrating. The value of this persistence lies between 0 (constantly changing direction) and 1 (no changes in direction). Additionally, we saw a positive correlation between the speed and persistence in RPE-1 cells, meaning that faster RPE-1 cells are also more persistent in their movement.

Fig 5. Effects of MiuA on migrating cells.

Fig 5

(a) Visual representation of “persistence”. A high persistence means little directional changes, whereas a low persistence indicates a cell that changes its direction a lot. Schematic representation of amoeboid migrating cells (b, e). Under confinement, RPE-1 LifeAct mCherry cells show no differences in speed and persistence (c, d). The same results occur when neutrophils migrate in confinement (f, g). A statistical analysis was performed using Student’s t test. n.s.: p > 0.05; *: p < 0.05; **: p < 0.01; and ***: p < 0.005. Number of cells: RPE-1: 109 control and 119 MiuA. Neutrophils: 56 control and 102 MiuA.

To confirm that this behavior is general to amoeboid movement and not just a property specific to RPE-1 cells, we repeated the same migration experiment in pll-g-PEG-coated channels using neutrophils (Fig 5e-5g). Like RPE-1 cells, neutrophils did not change their migration speed or persistence after the treatment with MiuA significantly. Their average speed was 4.172 µm/min in untreated cells and 5.363 µm/min in MiuA treated cells, and their persistence was 0.577 for untreated cells and 0.636 for MiuA treated ones. Although the correlation between speed and persistence was not as high as in RPE-1 cells, neutrophils still showed the same trend in which faster cells tend to migrate in a more persistent manner. Taken together, we conclude that the actin filament stabilization effect of MiuA has no significant effect on friction-based migration, confirming our hypothesis.

Conclusion

In this study we investigated the interplay between actin filament length, focal adhesions, adhesion forces, adhesion energy, and cell migration and explained that they are all interrelated.

First, we confirmed the actin filament stabilizing effects of MiuA in MEF cells and showed that the treatment does indeed elongate actin filaments in MEF cells without affecting the spreading area. This confirmed our hypothesis that MiuA stabilizes and elongates actin filaments in living cells regardless of the used cell line in this study.

Second, we tested how this stabilization of actin affects the size and number of focal adhesions and found an increase in the number of focal adhesions while reducing the size of individual focal adhesions. We also tested how the size and number of focal adhesions affect the adhesion properties of the cells. We found that RPE-1 cells treated with MiuA had more but smaller focal adhesions and adhered less, while their rupture length was unaffected.

Furthermore, our contractility measurements on RPE-1 cells revealed that MiuA does not affect the contractility.

We hypothesized that the actin filament stabilization would only affect adhesion-based migration (mesenchymal migration), since focal adhesions and adhesion properties were altered while contractility remained unaffected. Therefore, we expected that amoeboid migration, which does not rely on adhesion, would not be altered.

We have now confirmed this hypothesis and also explained our previous findings about the reduction of mesenchymal 2D migration of RPE-1 and MEF cells (S5 Fig) [23]. In our previous publication [23], we hypothesized that this was due to an increase in adhesion force. However, in this work we have now disproved this hypothesis by measuring a reduction of adhesion force and energy. Instead, we now conclude that the treatment with MiuA reduces adhesion properties, which impedes the cell from exerting the forces needed to perform mesenchymal migration.

On the other hand, when we placed RPE-1 cells and neutrophils in pll-g-PEG-coated microchannels and forced them to migrate in an amoeboid mode, neither their speed nor their persistence changed after the treatment with MiuA. This confirmed our hypothesis that non-adhesion-based migration would not be affected by MiuA.

Taken together, we conclude that MiuA treatment affects adhesion-based migration, but not amoeboid migration in cells.

We showed in this work that MiuA can be used as a reliable tool to alter cellular adhesion properties in cells while leaving cellular contractility unaffected. Further experiments using this tool will lead to a better understanding of the different mechanisms of migration in immune and cancer cells.

Supporting information

S1 Fig. Additional images of MEF cells.

Left: control, right: 5nM MiuA. Scale bar 20µm.

(TIF)

pone.0330071.s001.tif (597.6KB, tif)
S2 Fig. Dosage dependent effect of MiuA on RPE1 cells.

(a) Spreading area of RPE-1 wt cells on a fibronectin (25 µg/ml) coated glass surface. The treatment with 20nM of MiuA significantly increased the spreading area, whereas 5nM showed no significant effect. (b) Mean actin filament length per cell in RPE-1 wt cells. Treatment with 20nM MiuA significantly increased the mean actin filament length, while 5nM showed no significant effect. Number of cells: 35 (a), 30 (b). A statistical analysis was performed using Student’s t test. n.s.: p > 0.05; *: p < 0.05; **: p < 0.01; and ***: p < 0.005.

(TIF)

pone.0330071.s002.tif (137.6KB, tif)
S3 Fig. Trypsin assay for RPE-1 LifeAct mCherry cells.

Fully spread RPE-1 LifeAct mCherry cells were trypsinized while being monitored with a video microscope. Pictures were taken every 20 seconds where the time stamp (yellow label in the upper left corner) denotes the time after adding trypsin. The first picture “0 s” was taken immediately after trypsin was added. Top: Control cells treated with DMSO. Bottom: MiuA (20 nM) treated cells. Scale bar 20 μm.

(TIF)

pone.0330071.s003.tif (811.2KB, tif)
S4 Fig. Focal adhesion staining in migrating RPE-1 LifeAct mCherry cells and neutrophils.

From left to right: Paxillin immunostaining with zoomed in area (red square) in green. DAPI staining of the nucleus in yellow. Brightfield images of RPE-1 cells and neutrophils. Composite images of the paxillin, nucleus and brightfield images. From Top to bottom: (a) RPE-1 cells on 2D fibronectin (25 μg/ml) coated surface. (b) RPE-1 cells inside 10x10 μm PDMS microchannels with fibronectin coating. (c) RPE-1 cells on a PEG-coated surface. (d) RPE-1 cells in PEG-coated 10x10 μm PDMS microchannels. (e) Neutrophils on a PEG-coated 2D surface. (f) Neutrophils inside a PEG-coated 5x5 μm PDMS microchannel. Scale bars: 20 μm.

(TIF)

pone.0330071.s004.tif (1.5MB, tif)
S5 Fig. Effects of MiuA on mesenchymal migrating RPE-1 cells.

Schematic representation of a mesenchymal migrating cell on a fibronectin line (a). On these fibronectin lines, RPE-1 LifeAct mCherry cells treated with 20 nM MiuA reduced their speed (b) and persistence (c). A statistical analysis was performed using Student’s t test: n.s.: p > 0.05; *: p < 0.05; **: p < 0.01; and ***: p < 0.005. Number of cells: 55 control and 77 MiuA. Data replotted from Baltes et al. [23].

(TIF)

pone.0330071.s005.tif (222.3KB, tif)
S1 File. P-values Excel-file with all our p-values derived from the statistical tests performed on the data.

(XLSX)

pone.0330071.s006.xlsx (9.6KB, xlsx)
S2 File. Related article PDF-file of the related article mentioned in the text.

This article refers to reference Baltes et al. [23].

(PDF)

pone.0330071.s007.pdf (1.5MB, pdf)
S3 File. Calculation of contractile energy PDF-file containing a detailed description of the calculation of the contractile energy in cells on an elastic surface.

(PDF)

pone.0330071.s008.pdf (325KB, pdf)

Acknowledgments

We thank Ajinkya Ghagre and Allen Ehrlicher for their advice on the soft gel patterning technique PaCS, as well as Matthieu Piel and Jennifer Kasper for providing us with the cell lines.

Data Availability

All data, p-values and python codes are availabe from the database "figshare" via the following link: https://doi.org/10.6084/m9.figshare.26862634.v3 Full citation: Lautenschläger, Franziska (2024). Data, p-values and python3 codes for manuscript "Actin length in cellular adhesion and contractility". figshare. Dataset. https://doi.org/10.6084/m9.figshare.26862634.v3

Funding Statement

This research was supported by the German Research Foundation (SFB1027) and large- instrument funding under grant number INST 256/542-1 FUGG. The founders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. There was no additional funding received for this study.

References

  • 1.Liu Y-J, Le Berre M, Lautenschlaeger F, Maiuri P, Callan-Jones A, Heuzé M, et al. Confinement and low adhesion induce fast amoeboid migration of slow mesenchymal cells. Cell. 2015;160(4):659–72. doi: 10.1016/j.cell.2015.01.007 [DOI] [PubMed] [Google Scholar]
  • 2.Mihlan M, Glaser KM, Epple MW, Lämmermann T. Neutrophils: amoeboid migration and swarming dynamics in tissues. Front Cell Dev Biol. 2022;10:871789. doi: 10.3389/fcell.2022.871789 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Lämmermann T, Germain RN. The multiple faces of leukocyte interstitial migration. Semin Immunopathol. 2014;36(2):227–51. doi: 10.1007/s00281-014-0418-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Boisvieux-Ulrich E, Lainé MC, Sandoz D. Cytochalasin D inhibits basal body migration and ciliary elongation in quail oviduct epithelium. Cell Tissue Res. 1990;259(3):443–54. doi: 10.1007/BF01740770 [DOI] [PubMed] [Google Scholar]
  • 5.Bruijns RH, Bult H. Effects of local cytochalasin D delivery on smooth muscle cell migration and on collar-induced intimal hyperplasia in the rabbit carotid artery. Br J Pharmacol. 2001;134(3):473–83. doi: 10.1038/sj.bjp.0704281 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Goddette DW, Frieden C. Actin polymerization. The mechanism of action of cytochalasin D. J Biol Chem. 1986;261(34):15974–80. doi: 10.1016/s0021-9258(18)66662-1 [DOI] [PubMed] [Google Scholar]
  • 7.Schliwa M. Action of cytochalasin D on cytoskeletal networks. J Cell Biol. 1982;92(1):79–91. doi: 10.1083/jcb.92.1.79 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Coué M, Brenner SL, Spector I, Korn ED. Inhibition of actin polymerization by latrunculin A. FEBS Lett. 1987;213(2):316–8. doi: 10.1016/0014-5793(87)81513-2 [DOI] [PubMed] [Google Scholar]
  • 9.Pring M, Cassimeris L, Zigmond SH. An unexplained sequestration of latrunculin A is required in neutrophils for inhibition of actin polymerization. Cell Motil Cytoskeleton. 2002;52(2):122–30. doi: 10.1002/cm.10039 [DOI] [PubMed] [Google Scholar]
  • 10.Hayot C, Debeir O, Van Ham P, Van Damme M, Kiss R, Decaestecker C. Characterization of the activities of actin-affecting drugs on tumor cell migration. Toxicol Appl Pharmacol. 2006;211(1):30–40. doi: 10.1016/j.taap.2005.06.006 [DOI] [PubMed] [Google Scholar]
  • 11.Bubb MR, Senderowicz AM, Sausville EA, Duncan KL, Korn ED. Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actin. J Biol Chem. 1994;269(21):14869–71. [PubMed] [Google Scholar]
  • 12.Risinger AL, Du L. Targeting and extending the eukaryotic druggable genome with natural products: cytoskeletal targets of natural products. Nat Prod Rep. 2020;37(5):634–52. doi: 10.1039/c9np00053d [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ali R, Mir HA, Hamid R, Shah RA, Khanday FA, Bhat SS. Jasplakinolide attenuates cell migration by impeding Alpha-1-syntrophin protein phosphorylation in breast cancer cells. Protein J. 2021;40(2):234–44. doi: 10.1007/s10930-021-09963-y [DOI] [PubMed] [Google Scholar]
  • 14.Yang K, Luo M, Li H, Abdulrehman G, Kang L. Effects of jasplakinolide on cytotoxicity, cytoskeleton and apoptosis in two different colon cancer cell lines treated with m-THPC-PDT. Photodiagnosis Photodyn Ther. 2021;35:102425. doi: 10.1016/j.pdpdt.2021.102425 [DOI] [PubMed] [Google Scholar]
  • 15.Odaka C, Sanders ML, Crews P. Jasplakinolide induces apoptosis in various transformed cell lines by a caspase-3-like protease-dependent pathway. Clin Diagn Lab Immunol. 2000;7(6):947–52. doi: 10.1128/CDLI.7.6.947-952.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Bubb MR, Spector I, Beyer BB, Fosen KM. Effects of jasplakinolide on the kinetics of actin polymerization. An explanation for certain in vivo observations. J Biol Chem. 2000;275(7):5163–70. doi: 10.1074/jbc.275.7.5163 [DOI] [PubMed] [Google Scholar]
  • 17.Wang S, Crevenna AH, Ugur I, Marion A, Antes I, Kazmaier U, et al. Actin stabilizing compounds show specific biological effects due to their binding mode. Sci Rep. 2019;9(1):9731. doi: 10.1038/s41598-019-46282-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Moser C, Rüdiger D, Förster F, von Blume J, Yu P, Kuster B, et al. Persistent inhibition of pore-based cell migration by sub-toxic doses of miuraenamide, an actin filament stabilizer. Sci Rep. 2017;7(1):16407. doi: 10.1038/s41598-017-16759-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Sumiya E, Shimogawa H, Sasaki H, Tsutsumi M, Yoshita K, Ojika M, et al. Cell-morphology profiling of a natural product library identifies bisebromoamide and miuraenamide A as actin filament stabilizers. ACS Chem Biol. 2011;6(5):425–31. doi: 10.1021/cb1003459 [DOI] [PubMed] [Google Scholar]
  • 20.Karmann L, Schultz K, Herrmann J, Müller R, Kazmaier U. Total syntheses and biological evaluation of miuraenamides. Angew Chem Int Ed Engl. 2015;54(15):4502–7. doi: 10.1002/anie.201411212 [DOI] [PubMed] [Google Scholar]
  • 21.Iizuka T, Fudou R, Jojima Y, Ogawa S, Yamanaka S, Inukai Y, et al. Miuraenamides A and B, novel antimicrobial cyclic depsipeptides from a new slightly halophilic myxobacterium: taxonomy, production, and biological properties. J Antibiot (Tokyo). 2006;59(7):385–91. doi: 10.1038/ja.2006.55 [DOI] [PubMed] [Google Scholar]
  • 22.Gegenfurtner FA, Zisis T, Al Danaf N, Schrimpf W, Kliesmete Z, Ziegenhain C, et al. Transcriptional effects of actin-binding compounds: the cytoplasm sets the tone. Cell Mol Life Sci. 2018;75(24):4539–55. doi: 10.1007/s00018-018-2919-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Baltes C, Thalla DG, Kazmaier U, Lautenschläger F. Actin stabilization in cell migration. Front Cell Dev Biol. 2022;10:931880. doi: 10.3389/fcell.2022.931880 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Lange JR, Fabry B. Cell and tissue mechanics in cell migration. Exp Cell Res. 2013;319(16):2418–23. doi: 10.1016/j.yexcr.2013.04.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.SenGupta S, Parent CA, Bear JE. The principles of directed cell migration. Nat Rev Mol Cell Biol. 2021;22(8):529–47. doi: 10.1038/s41580-021-00366-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Legerstee K, Houtsmuller AB. A layered view on focal adhesions. Biology (Basel). 2021;10(11):1189. doi: 10.3390/biology10111189 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Broussard JA, Webb DJ, Kaverina I. Asymmetric focal adhesion disassembly in motile cells. Curr Opin Cell Biol. 2008;20(1):85–90. doi: 10.1016/j.ceb.2007.10.009 [DOI] [PubMed] [Google Scholar]
  • 28.Wehrle-Haller B. Structure and function of focal adhesions. Curr Opin Cell Biol. 2012;24(1):116–24. doi: 10.1016/j.ceb.2011.11.001 [DOI] [PubMed] [Google Scholar]
  • 29.Wehrle-Haller B, Imhof B. The inner lives of focal adhesions. Trends Cell Biol. 2002;12(8):382–9. doi: 10.1016/s0962-8924(02)02321-8 [DOI] [PubMed] [Google Scholar]
  • 30.Hawkins RJ, Piel M, Faure-Andre G, Lennon-Dumenil AM, Joanny JF, Prost J, et al. Pushing off the walls: a mechanism of cell motility in confinement. Phys Rev Lett. 2009;102(5):058103. doi: 10.1103/PhysRevLett.102.058103 [DOI] [PubMed] [Google Scholar]
  • 31.Azioune A, Carpi N, Tseng Q, Théry M, Piel M. Protein micropatterns: a direct printing protocol using deep UVs. Methods Cell Biol. 2010;97:133–46. doi: 10.1016/S0091-679X(10)97008-8 [DOI] [PubMed] [Google Scholar]
  • 32.Ghagre A, Amini A, Srivastava LK, Tirgar P, Khavari A, Koushki N, et al. Pattern-based contractility screening, a reference-free alternative to traction force microscopy methodology. ACS Appl Mater Interfaces. 2021;13(17):19726–35. doi: 10.1021/acsami.1c02987 [DOI] [PubMed] [Google Scholar]
  • 33.Landau LD, Lifshits EM, Kosevich AM, Lifshitz EM, Pitaevskii LP. Theory of elasticity: Volume 7. Elsevier; 1986. [Google Scholar]
  • 34.Vesperini D, Montalvo G, Qu B, Lautenschläger F. Characterization of immune cell migration using microfabrication. Biophys Rev. 2021;13(2):185–202. doi: 10.1007/s12551-021-00787-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–82. doi: 10.1038/nmeth.2019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Ershov D, Phan M-S, Pylvänäinen JW, Rigaud SU, Le Blanc L, Charles-Orszag A, et al. TrackMate 7: integrating state-of-the-art segmentation algorithms into tracking pipelines. Nat Methods. 2022;19(7):829–32. doi: 10.1038/s41592-022-01507-1 [DOI] [PubMed] [Google Scholar]
  • 37.Tinevez J-Y, Perry N, Schindelin J, Hoopes GM, Reynolds GD, Laplantine E, et al. TrackMate: an open and extensible platform for single-particle tracking. Methods. 2017;115:80–90. doi: 10.1016/j.ymeth.2016.09.016 [DOI] [PubMed] [Google Scholar]
  • 38.Goffin JM, Pittet P, Csucs G, Lussi JW, Meister J-J, Hinz B. Focal adhesion size controls tension-dependent recruitment of alpha-smooth muscle actin to stress fibers. J Cell Biol. 2006;172(2):259–68. doi: 10.1083/jcb.200506179 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Burridge K, Guilluy C. Focal adhesions, stress fibers and mechanical tension. Exp Cell Res. 2016;343(1):14–20. doi: 10.1016/j.yexcr.2015.10.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Balaban NQ, Schwarz US, Riveline D, Goichberg P, Tzur G, Sabanay I, et al. Force and focal adhesion assembly: a close relationship studied using elastic micropatterned substrates. Nat Cell Biol. 2001;3(5):466–72. doi: 10.1038/35074532 [DOI] [PubMed] [Google Scholar]
  • 41.Schwarz US, Balaban NQ, Riveline D, Bershadsky A, Geiger B, Safran SA. Calculation of forces at focal adhesions from elastic substrate data: the effect of localized force and the need for regularization. Biophys J. 2002;83(3):1380–94. doi: 10.1016/S0006-3495(02)73909-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Tapial Martínez P, López Navajas P, Lietha D. FAK structure and regulation by membrane interactions and force in focal adhesions. Biomolecules. 2020;10(2):179. doi: 10.3390/biom10020179 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Gallant ND, Michael KE, García AJ. Cell adhesion strengthening: contributions of adhesive area, integrin binding, and focal adhesion assembly. Mol Biol Cell. 2005;16(9):4329–40. doi: 10.1091/mbc.e05-02-0170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Sankaran S, Jaatinen L, Brinkmann J, Zambelli T, Vörös J, Jonkheijm P. Cell adhesion on dynamic supramolecular surfaces probed by fluid force microscopy-based single-cell force spectroscopy. ACS Nano. 2017;11(4):3867–74. doi: 10.1021/acsnano.7b00161 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Gunaratnam G, Leisering R, Wieland B, Dudek J, Miosge N, Becker SL, et al. Characterization of a unique attachment organelle: single-cell force spectroscopy of Giardia duodenalis trophozoites. Nanoscale. 2024;16(14):7145–53. doi: 10.1039/d4nr00122b [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Gunaratnam G, Dudek J, Jung P, Becker SL, Jacobs K, Bischoff M, et al. Quantification of the adhesion strength of candida albicans to tooth enamel. Microorganisms. 2021;9(11):2213. doi: 10.3390/microorganisms9112213 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Huber R, Bode W. Structural basis of the activation and action of trypsin. Acc Chem Res. 1978;11(3):114–22. doi: 10.1021/ar50123a006 [DOI] [Google Scholar]
  • 48.Cramer LP. Molecular mechanism of actin-dependent retrograde flow in lamellipodia of motile cells. Front Biosci. 1997;2:d260-70. doi: 10.2741/a189 [DOI] [PubMed] [Google Scholar]
  • 49.Ruprecht V, Wieser S, Callan-Jones A, Smutny M, Morita H, Sako K, et al. Cortical contractility triggers a stochastic switch to fast amoeboid cell motility. Cell. 2015;160(4):673–85. doi: 10.1016/j.cell.2015.01.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.García-Arcos JM, Ziegler J, Grigolon S, Reymond L, Shajepal G, Cattin CJ, et al. Advected percolation in the actomyosin cortex drives amoeboid cell motility. Cold Spring Harbor Laboratory; 2022. doi: 10.1101/2022.07.14.500109 [DOI] [PubMed] [Google Scholar]
  • 51.García-Arcos JM, Jha A, Waterman CM, Piel M. Blebology: principles of bleb-based migration. Trends Cell Biol. 2024;34(10):838–53. doi: 10.1016/j.tcb.2024.02.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Ennomani H, Letort G, Guérin C, Martiel J-L, Cao W, Nédélec F, et al. Architecture and connectivity govern actin network contractility. Curr Biol. 2016;26(5):616–26. doi: 10.1016/j.cub.2015.12.069 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Stricker J, Falzone T, Gardel ML. Mechanics of the F-actin cytoskeleton. J Biomech. 2010;43(1):9–14. doi: 10.1016/j.jbiomech.2009.09.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Hawkins RJ, Voituriez R. Mechanisms of cell motion in confined geometries. Math Model Nat Phenom. 2010;5(1):84–105. doi: 10.1051/mmnp/20105104 [DOI] [Google Scholar]
  • 55.Thewes N, Thewes A, Loskill P, Peisker H, Bischoff M, Herrmann M, et al. Stochastic binding of Staphylococcus aureus to hydrophobic surfaces. Soft Matter. 2015;11(46):8913–8919. doi: 10.1039/C5SM00963D [DOI] [PubMed] [Google Scholar]
  • 56.Dufrêne YF, Pelling AE. Force nanoscopy of cell mechanics and cell adhesion. Nanoscale. 2013;5(10):4094. doi: 10.1039/c3nr00340j [DOI] [PubMed] [Google Scholar]
  • 57.Spengler C, Thewes N, Nolle F, Faidt T, Umanskaya N, Hannig M, et al. Enhanced adhesion of Streptococcus mutans to hydroxyapatite after exposure to saliva. Journal of Molecular Recognition. 2017;30(7):null. doi: 10.1002/jmr.2615 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Florian Rehfeldt

7 Apr 2025

Dear Dr. Lautenschläger,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 22 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Florian Rehfeldt

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.-->--> -->-->Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at -->-->https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and -->-->https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf-->--> -->-->2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse.-->--> -->-->3. Thank you for stating in your Funding Statement: -->-->This research was supported by the German Research Foundation (SFB1027) and large-instrument funding under grant number INST 256/542-1 FUGG. -->--> -->-->Please provide an amended statement that declares all the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. -->-->Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.-->--> -->-->4. We note that Figures Fig 2G and Figure S3B-C in your submission contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.-->--> -->-->We require you to either present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or remove the figures from your submission:-->--> -->-->a. You may seek permission from the original copyright holder of Figures Fig 2G and Figure S3B-C to publish the content specifically under the CC BY 4.0 license. -->-->We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:-->-->“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”-->-->Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.  -->-->In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”-->--> -->-->b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.-->--> -->-->5. We notice that your supplementary figures are uploaded with the file type 'Figure'. Please amend the file type to 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list.-->?>

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1:  The authors have submitted a decently written manuscript describing the effects of a new compound miuraenamide A (MiuA), recently found to affect actin dynamics, on focal adhesions, cell contractility and migration. They show that in cell culture the treatment with MiuA in two cell types reduce average focal adhesion size but increase the number of adhesions. They also find that the strength of these adhesions, despite being higher in number, are less adhesive. The authors also show that amoeboid type migration is unaffected by MiuA treatment. Overall the experiments seem to be well-performed and nearly adequate analysis. However, the overall writing style needs some adjustment for clarity as well as some additional questions need to be addressed before this paper should be accepted for publication in PONE. The following issues should be addressed:

(1) The way the manuscript is written seems very redundant in many places. For example, the Introduction section is extremely long and is written to include the results. Provide only a quick summary of your results (not going figure by figure) in the introduction and keep the results section that you do have for the detailed explanation of the figures. On the first read of the manuscript, I thought that the introduction’s run through of the figures was indeed the results section.

(2) The authors use two cell types for the beginning two figure’s worth of experiments but then drop the use of the MEF cells. Why is this? MEF cells are commonly used for cell migration experiments, especially in 2D settings, so some analysis of their behavior upon MiuA treatment would be helpful to the field and further the impact of this paper.

(3) On a similar note, the authors don’t seem to address 2D migration parameters, which would be greatly beneficial to the broader cell migration community (and again, boost the impact of this publication). I suggest that the authors analyze the effect of MiuA treatment on 2D migration parameters such as speed, persistence, directionality, etc. These parameters are only analyzed in the context of the PDMS confinement channels during amoeboid migration. Is it known how MiuA affects unconfined 2D migration? Such a change in focal adhesions parameters surely affects 2D migration.

(4) In Figure 1, the authors show only the spreading area and actin filament length analysis for MEF cells but not RPE-1 cells – why? There seems to be a significant change in the spreading area for RPE-1 cells based on the images in panel (1C). Since the authors rely heavily on RPE-1 cells throughout the manuscript, this should not be omitted here.

Reviewer #2:  The authors demonstrate the effect of an actin-stabilizing agent (MiuA) on the adhesivity, contractility and migration of two cell types. They show that although focal adhesions are impacted by this drug, the contractility and ability to migrate in the amoeboid mode are not.

These findings are an interesting addition to a growing body of work on cell mechanics and cell-substrate mechanical interactions. However, some more mechanistic insights and explanation of the data could strengthen this study, and some of the rationale is not well-described. Some specific concerns and questions are:

1. The Introduction paragraphs 3 and 4 are essentially a summary of the Results, which is unconventional. As a reader, I am interested in knowing more about the rationale and background of the study. what is known about the biochemical mechanism of how MiuA works: does it inhibit actin polymerization or severing, for example? how does it interact with actin binding proteins? what are the pros and cons of using this as a stabilizng agent vs. jusplakinolide or phalloidin? what are the RPE1 and MEF cell types and why are they the suitable candidates in this study?

2. In Fig. 1, it is abrupt to start with quantification before showing cell images first. Also, why quantification is shown only for MEF cell type only in Figs 1a and 1b and not for RPE1?

3. Fig. 1c focuses on individual cells, but to be convincing the authors should also show a wider field of view with many cells, so that the reader can see the representative behavior.

4. The MiuA treated MEF cell shown has an interesting spindle-like morphology. Have the authros tried to quantify this effect? A quantification of the cell aspect ratio would reflect this, for example. It will be interesting to see how cell morphology is affected in addition to cell area, by MiuA.

5. There should be some explanation, at least qualitative, why the contractility is not affected although adhesivity is.

6. Why are neutrophils intriduced for motility measurements, and not MEF? do these not migrate?? there could be a cartoon to illustrate how persistence is measured. In addition to adhesions, can the 1D vs 2D nature of the migration also play a role?

7. Similar to Introduction, the Conclusion could be stronger if there was some discussion of the broader context of this work. How does jusplakinolide affect these quantities: cell adhesivity, contractility, and migration for example?

8. The images provided are low resolution at least in the reviewer's copy. Perhaps the images analyzed should also be shared in high resolution alongside the supplementary data.

9. There is some informal/colloquial use of English in some places that seem out of place in a technical document. Sentences should not begin with "And" as in line 63 or 88, and "very well" is not a quantifiable statement in line 76, just to take two examples. The authors could use better human proofreading in addition to using AI-based tools which are not often adequate for this purpose.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 Sep 5;20(9):e0330071. doi: 10.1371/journal.pone.0330071.r002

Author response to Decision Letter 1


2 Jun 2025

We thank the editor and the reviewers for their time reading our manuscript and the patience while waiting for our response. We replied to all concernes and questions posed by the editor and the reviewers. Our replies can be seen in the attached files under "Reply to editor and reviwers.pdf".

Attachment

Submitted filename: Reply to editor and reviewers.pdf

pone.0330071.s010.pdf (1.1MB, pdf)

Decision Letter 1

Florian Rehfeldt

2 Jul 2025

Dear Dr. Lautenschläger,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The manuscript was substantially improved by the revision and addressing the issues of both referees. However, before acceptance for publication it is imperative to address the last open points raised by referee 2.

Please submit your revised manuscript by Aug 16 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Florian Rehfeldt

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: The authors have satisfied all of my concerns. I recommend an acceptance of this manuscript for publication.

Reviewer #2: The authors have significantly improved the clarity of the manuscript in this revised version. They have now answered most of my questions, but I have some more remaining comments which I believe should be addressed before final acceptance.

1.The authors explain that the some of the quantification for RPE-1 cells, corresponding to the results in Fig. 1, were carried out in their previous publication, Ref.22. However, in that study, the MiuA-treated RPE-1 cells increased their spread area, whereas MiuA-treated MEF cells showed no change in spread area. They think this puzzling result is because different doses of MiuA were used for the two cell lines. This raises the obvious question: why not do the same dosage for both cell lines to establish this? Is there any practical limitation to this?

2. Related to above, the authors discuss that one of the disadvantages of using jasplakinolide is that its effect is highly dosage dependent. However, they also found that MiuA's effect is also dosage dependent. How sensitive is this dosage dependence? Have they tried for example, different doses of MiuA on RPE-1 or MEF?

3. In Fig. 1a, the MiuA treated MEF cells shown look distinctly smaller by eye than the control MEF cells. Why is this? Is this image not a representative sample of the whole population of cells? In this case, it might be more convincing to choose a different image, or show additional images in the SI.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

PLoS One. 2025 Sep 5;20(9):e0330071. doi: 10.1371/journal.pone.0330071.r004

Author response to Decision Letter 2


23 Jul 2025

We thank the editor and the reviewers for their time reading our manuscript and the patience while waiting for our response. We replied to all concernes and questions posed by the editor and the reviewers. Our replies can be seen in the attached files under "Reply to editor and reviewers.pdf".

Attachment

Submitted filename: Reply to Editor and reviewer.pdf

pone.0330071.s011.pdf (374.6KB, pdf)

Decision Letter 2

Florian Rehfeldt

27 Jul 2025

Modulation of Cellular Adhesion, Contractility, and Migration by MiuA: A Comprehensive Analysis of Its Biomechanical Impact

PONE-D-24-57233R2

Dear Dr. Lautenschläger,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Florian Rehfeldt

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #2: Yes

**********

Reviewer #2: The authors have shown additional data and satisfactorily answered my remaining questions about dosage dependence of miuA and additional cell images. I think this is technically sound and interesting work, and is ready to be accepted for publication.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #2: No

**********

Acceptance letter

Florian Rehfeldt

PONE-D-24-57233R2

PLOS ONE

Dear Dr. Lautenschläger,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Florian Rehfeldt

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Additional images of MEF cells.

    Left: control, right: 5nM MiuA. Scale bar 20µm.

    (TIF)

    pone.0330071.s001.tif (597.6KB, tif)
    S2 Fig. Dosage dependent effect of MiuA on RPE1 cells.

    (a) Spreading area of RPE-1 wt cells on a fibronectin (25 µg/ml) coated glass surface. The treatment with 20nM of MiuA significantly increased the spreading area, whereas 5nM showed no significant effect. (b) Mean actin filament length per cell in RPE-1 wt cells. Treatment with 20nM MiuA significantly increased the mean actin filament length, while 5nM showed no significant effect. Number of cells: 35 (a), 30 (b). A statistical analysis was performed using Student’s t test. n.s.: p > 0.05; *: p < 0.05; **: p < 0.01; and ***: p < 0.005.

    (TIF)

    pone.0330071.s002.tif (137.6KB, tif)
    S3 Fig. Trypsin assay for RPE-1 LifeAct mCherry cells.

    Fully spread RPE-1 LifeAct mCherry cells were trypsinized while being monitored with a video microscope. Pictures were taken every 20 seconds where the time stamp (yellow label in the upper left corner) denotes the time after adding trypsin. The first picture “0 s” was taken immediately after trypsin was added. Top: Control cells treated with DMSO. Bottom: MiuA (20 nM) treated cells. Scale bar 20 μm.

    (TIF)

    pone.0330071.s003.tif (811.2KB, tif)
    S4 Fig. Focal adhesion staining in migrating RPE-1 LifeAct mCherry cells and neutrophils.

    From left to right: Paxillin immunostaining with zoomed in area (red square) in green. DAPI staining of the nucleus in yellow. Brightfield images of RPE-1 cells and neutrophils. Composite images of the paxillin, nucleus and brightfield images. From Top to bottom: (a) RPE-1 cells on 2D fibronectin (25 μg/ml) coated surface. (b) RPE-1 cells inside 10x10 μm PDMS microchannels with fibronectin coating. (c) RPE-1 cells on a PEG-coated surface. (d) RPE-1 cells in PEG-coated 10x10 μm PDMS microchannels. (e) Neutrophils on a PEG-coated 2D surface. (f) Neutrophils inside a PEG-coated 5x5 μm PDMS microchannel. Scale bars: 20 μm.

    (TIF)

    pone.0330071.s004.tif (1.5MB, tif)
    S5 Fig. Effects of MiuA on mesenchymal migrating RPE-1 cells.

    Schematic representation of a mesenchymal migrating cell on a fibronectin line (a). On these fibronectin lines, RPE-1 LifeAct mCherry cells treated with 20 nM MiuA reduced their speed (b) and persistence (c). A statistical analysis was performed using Student’s t test: n.s.: p > 0.05; *: p < 0.05; **: p < 0.01; and ***: p < 0.005. Number of cells: 55 control and 77 MiuA. Data replotted from Baltes et al. [23].

    (TIF)

    pone.0330071.s005.tif (222.3KB, tif)
    S1 File. P-values Excel-file with all our p-values derived from the statistical tests performed on the data.

    (XLSX)

    pone.0330071.s006.xlsx (9.6KB, xlsx)
    S2 File. Related article PDF-file of the related article mentioned in the text.

    This article refers to reference Baltes et al. [23].

    (PDF)

    pone.0330071.s007.pdf (1.5MB, pdf)
    S3 File. Calculation of contractile energy PDF-file containing a detailed description of the calculation of the contractile energy in cells on an elastic surface.

    (PDF)

    pone.0330071.s008.pdf (325KB, pdf)
    Attachment

    Submitted filename: Reply to editor and reviewers.pdf

    pone.0330071.s010.pdf (1.1MB, pdf)
    Attachment

    Submitted filename: Reply to Editor and reviewer.pdf

    pone.0330071.s011.pdf (374.6KB, pdf)

    Data Availability Statement

    All data, p-values and python codes are availabe from the database "figshare" via the following link: https://doi.org/10.6084/m9.figshare.26862634.v3 Full citation: Lautenschläger, Franziska (2024). Data, p-values and python3 codes for manuscript "Actin length in cellular adhesion and contractility". figshare. Dataset. https://doi.org/10.6084/m9.figshare.26862634.v3


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES